Adil Hussen currently serves as an Associate Scientist at AstraZeneca since November 2023, focusing on the development and optimization of purification processes for monoclonal antibodies and protein-based therapeutics, while also contributing to regulatory submissions and documentation. Prior experience includes conducting undergraduate research at Ashland University, where Adil Hussen investigated alpha-crystallin lens proteins and co-authored a research paper on vertebrate lens-crystallin proteins. Additionally, at the University of Kansas Medical Center, Adil Hussen performed structural and biochemical studies on DNA base excision repair proteins, alongside other research in genome stability and DNA repair. Adil Hussen holds a Bachelor's degree in Biology from Ashland University, completed in 2021.
This person is not in the org chart
This person is not in any teams
This person is not in any offices